Article 3.4 ofEC directive 89/381 requires member states to take "all necessary measures to promote Community self-sufficiency in human blood or human plasma " and, for this purpose, to "encourage the voluntary unpaid donation of blood and plasma ". This paper presents an ethical case in support of the policy of voluntary, unpaid donation.
Introduction
Recent newspaper stories about leaking blood bags, the increasing demand for blood as a result of more operations, the sale of surplus blood products to foreign countries and the reform of the blood transfusion service' have raised vital questions about the most effective and ethical way of ensuring an adequate supply of blood and blood products. One major question is: "Is it ethical, in order to ensure an adequate supply of blood and blood products, to pay donors?" European Community directive 89/381 requires member states to take "all necessary measures to promote Community self-sufficiency in human blood or human plasma" and, for this purpose, to "encourage the voluntary unpaid donation of blood and plasma". The ethical desirability of this policy appears to have been assumed rather than articulated, not least in the UK where there has been a dearth of political, public and ethical debate. This paper, based on the author's contribution to an EC-funded research project into the ethics of the EC policy,2 presents an ethical case in favour ofvoluntary, unpaid donation. It 
II. Altruism and social solidarity
A major argument for exclusive reliance on unpaid donation is that, unlike paid donation, it promotes altruism and social solidarity. Titmuss, in his landmark study of blood donation and social policy, wrote that his study was, essentially, about "the role of altruism in modem society".5
This principle of unremunerated donation has lain at the heart of the UK National Blood Transfusion Service (now the National Blood Authority) since its inception over half a century ago. The service depends heavily on donors' good will. As one NBTS leaflet for donors states, having listed ten "good things" that come out of blood:
"The 11th good thing that comes out of blood cannot be scientifically described, so we won't attempt it. All the same, we want to take the opportunity of thanking you for it. It is called your good will, and it happens to be the fuel that runs the NBTS".6
Such altruism was evident during the summer of 1995 after thousands of units were destroyed because of faulty bags. One Similarly, in a survey reported in 1991, current and lapsed donors were asked why they gave blood. Their answers fell broadly into three categories. The first, "social conscience", was mentioned by 61% and the reasons given included helping others (34%); doing the right thing (17%); doing one's public duty (11%), and benefiting the community (5%). The second, "to fulfil need", was cited by 41% and reasons given included the fact that blood was needed (25%); to help save lives (11%); for accidents (4%); for operations (2%) and because the donor had a rare blood group (3%). The final category, "personal benefit", was mentioned by 40% and included the reasons that the donor or his family might need blood (24%); the donor's personal experience of transfusion (8%); the satisfaction at helping (4%); and the belief that it was healthy to donate (4%).9 The survey indicates that altruism remains the primary motivation for donation.
To allow payment would not only encourage donation for non-altruistic motives, but might also discourage unpaid donation. Writing in 1973, Peter Singer concluded that the available evidence did indeed suggest that paying some people discouraged others from donating altruistically. This was supported both by the fact that in countries dependent on unpaid as opposed to paid donation, supply tended to keep up with increases in demand, and by the replies to Titmuss's questionnnaire. Singer observed:
"The nature of these replies -not the mere fact that the donors were altruistically motivated, but their attitudes toward the National Health Service in general and the Blood Transfusion Service in particular -is evidence that at least for some people the possibility of others buying and selling blood would destroy the inspiring force behind their own donations. At the same time, these replies enable us to understand why the existence of a commercial system could be expected to make a difference. The idea that others are depending on one's generosity and concern, that one may oneself, in an emergency, need the assistance of a stranger, the feeling that there is still at least this vital area in which we must rely on the good will of others rather than the profit motive -all these vague ideas and feelings are incompatible with the existence of a market in blood". 10 It seems reasonable to conclude that a significant number of donors who presently donate for altruistic reasons and reasons of social solidarity would cease to donate if payment were introduced. Those who are happy to give, and be seen to be giving, might well be reluctant to sell, or thought to be selling.
Finally, a move towards paid donation might also undermine feelings of altruism and social solidarity in the broader community.With increasing evidence of social disintegration and social isolation in British society and in the light of widespread concern about the growth of commercialisation, not least in the National Health Service, is there not a danger that paid donation could be, or at least could be perceived to be, a further instance of such trends? And might not paid donation then encourage further commercialisation at the expense of social solidarity? As Titmuss asked: "If blood is morally sanctioned as something to be bought and sold what ultimately is the justification for not promoting individualistic private markets in other component areas of medical care, and in education, social security, welfare services, child foster care, social work skills, the use of patients and clients for professional training, and other 'social service' institutions and processes"?1'
And it is noteworthy that those arguing for paid donation typically openly advocate the replacement of the "gift relationship" by impersonal market forces.'2 Titmuss stressed that "the ways in which society organizes and structures its social institutions -and particularly its health and welfare systems -can encourage or discourage the altruistic in man; such systems can foster integration or alienation. . ." 13 It seems that voluntary donation, rather than the market, is more likely to promote social integration and community. As Murray observes: "Gifts to strangers affirm the solidarity of the community over and above the depersonalizing, alienating forces of mass society and market relations. They signal that self-interest is not the only significant human motivation. And they express the moral belief that it is good to minister to fundamental human needs, needs for food, health care, and shelter.... These universal needs irrevocably tie us together in a community of needs, with a shared desire to satisfy them, and see them satisfied in others". 14 He adds that purely economic analyses of blood procurement ask the wrong question: "We should not inquire: 'How can we obtain the most blood at the least cost?' but 'What sort of society do we want?' ".'5
As for encouraging altruism, Singer' 
III Safety
Given that payment exercises a greater pull on the poor than the rich, that the poor tend to be less healthy, and that they have a financial interest in concealing any ill-health, it is unsurprising that donations from paid donors tend to be less safe than those from unpaid donors. As the cellular components of blood cannot be virally inactivated, and tests for infection are not completely reliable, safety favours unpaid donation.
However, plasma products can be virally inactivated, and it is widely accepted that plasma products manufactured by reputable commercial companies from paid donor plasma are as safe as products made from unpaid donor plasma. The evidence indicates that although plasma from paid donors tends to be less safe than that from unpaid donors, whether the donor is paid is only one element in the safety equation. Other elements, including donor screening and viral inactivation procedures are no less important in ensuring the maximum safety of plasma products. Plasma products which are derived from paid and well-screened donors and which are subjected to effective viral inactivation procedures are likely to be much safer than plasma from unpaid and poorly-screened donors which is not virally inactivated. In other words, non-payment no more ensures safety than payment precludes safety. 16 However, as Piet Hagen concludes: "If proper selection is carried out, the unpaid donor population is likely to be healthier than the paid donor population".17 And Van Aken's review of the evidence concludes: "What is clear, and irrefutable on the basis of published evidence, is that the ... tests in the commercial sector define a population which clearly represents a greater risk to potential recipients".'8 Further, however effective viral deactivaction may currently be, there is always the risk of error. There is also the risk ofhitherto undiscovered viruses. HIV is a case in point: it was not absent from voluntary donor plasma but the heaviest contamination was in commercial plasma. More recently, concern has been raised about possible transmission by transfusion of Creutzfeldt-Jakob disease.
The argument from safety would, therefore, appear to apply not only to whole blood, but even, albeit less forcefully, to plasma products. It seems, therefore, that on grounds of safety the more prudent policy is to encourage blood and blood products from unpaid donors.
IV Exploitation
A further argument is that the use of paid blood or plasma donors involves a significant risk of exploiting the poor and socially disadvantaged. The financial remuneration will act as a far more powerful inducement to the poor than the rich. This objection is, of course, related to the issue of safety for, as has been well documented, the poor tend to be in a worse state of health than the affluent. Titmuss graphically illustrated this objection in relation to some blood collection centres in the US which used many from "Skid-Row". Referring to unethical experimentation and plasmapheresis, he observed:
"In these expanding fields of human experimentation -as with plasmapheresis programs -virtually all the strangers who give, by inducement, for money or in captive situations, are poor people; the indigent, the deprived, the educationally handicapped, the socially inadequate (in and out of prisons and other institutions), and all those described by an American sociologist as 'inept' in advancing the hypothesis that modern economic systems 'utilize the inept more efficiently"'. 1
A counter-argument is that Titmuss was writing over twenty years ago about a country where, unlike now, paid blood donation was commonplace, and that the danger of exploitation is one which can be minimised. However, one survey involving almost 10,000 paid plasma donors revealed that over 300/0 had donated more than 18 times over a period of only three months.20 Frequent red-cell donations endanger health by inducing iron deficiency and its consequences and there is also concern about the possible risks of frequent plasma donation.
The risk of exploitation is clearly real and, however scrupulous reputable companies are in seeking to guard against it, cannot be ignored in deciding whether, as a matter of social policy, to discourage paid blood and plasma donation. And however minimal the risk might be in a system run by a reputable company and closely inspected by regulatory authorities, the risk of abuse remains, even in a first-world country such as the US, let alone less developed nations.
Moreover, if paid donation were condoned by the EC, there is a surely a danger that this might encourage less developed countries to embark (or continue) on the path of paid donation, with the consequent risk of widespread and serious exploitation. Might this not produce the objectionable situation where citizens of poorer nations are used as a resource to supply the needs of citizens of wealthier nations? Or even the grotesque scenario where citizens of poorer nations cannot afford to buy their own blood? In 1975 the World Health Assembly expressed serious concern that the activities of private companies seeking to establish paid blood and plasma centres in developing countries might interfere with efforts to establish national transfusion services based on unpaid donation.2' V Commercialisation of the human body To the extent that paying donors for their blood tends to treat (or could be perceived as treating) a part of the human body as property, it arguably devalues the human body. Do not the buyer and seller, and the community which endorses (and legally enforces) such a transaction, inevitably depersonalise the human body and treat it as something suited for commercial exchange? If so, does this not promote an instrumental view of human beings, as means rather than as ends, as moral and legal objects rather than subjects? Does it not encourage a perception of the donor, by others and by him or herself, as a source of raw material to be exploited? Might this not, moreover, open up disturbing possibilities of treating other bodily parts as chattels? Titmuss feared so: "If blood is considered in theory, in law, and is treated in practice as a trading commodity then ultimately human hearts, kidneys, eyes and other organs of the body may also come to be treated as commodities to be bought and sold in the marketplace".22
A counter-argument may be that, while such ethical objections are valid in relation to human beings and human organs, they are invalid in relation to renewable parts of the body. Who, it may be argued, would object to the sale of hair or urine? But is blood (an organ, albeit renewable) not more analagous to a kidney, the sale of which is illegal, than to urine? Murray makes the point that whereas the sale of urine or hair would be unlikely to cause a great moral outcry, such products are "less central to what characterizes living human persons, members of the human community" than organs and blood. He adds: "In any case, the nature of the gift, its meaning and significance within the community, will determine whether it belongs to the realm of commodities or the circle of gifts".'5 Although blood is a renewable bodily product, it is surely invested by the community with an undeniably special symbolic significance, and the social and moral meaning of donating blood -the altruistic donation of a life or health-saving gift from one person to another -is entirely different from the alienation of waste products such as urine.
Conclusions
There would appear to be at least five sound reasons for discouraging, as a matter of social policy, paid donation of blood and plasma. Institute for Bioethics, 1994. 3 An internationally accepted definition of "self-sufficiency" is "the provision of blood and blood products from within a population to satisfy the clinical needs of that population". However, the UK has opted for a more relaxed definition of "self-sufficiency" as the provision of a sufficient range and quality of domestically-sourced blood products to meet the needs of all patients whose clincians prefer these to other products. Van 
